Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 26, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 October 2026 - 15:00

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 26, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/takhzyro

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters